IDEAYA Biosciences, Inc.

NASDAQ:IDYA

25.61 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 0003.9238.0383.5447.884.02229.6995.85111.3592.9638.9768.7567.24710.5718.9670000000000
Cost of Revenue 01.0971.0821.0240.9860.9980.960.5580.9251.2040.4640.42515.50314.97911.56612.05110.0258.5969.0268.5418.923000000
Gross Profit 0-1.097-1.0822.8997.0522.5466.923.46428.7744.64710.8952.538-6.527-6.223-4.319-1.48-1.058-8.596-9.026-8.541-8.923000000
Gross Profit Ratio 0000.7390.8770.7180.8780.8610.9690.7940.9590.857-0.727-0.711-0.596-0.14-0.1180000000000
Reseach & Development Expenses 57.15254.53342.80538.7733.70129.17827.85924.71422.37222.79619.65616.10915.50314.97911.56612.05110.0248.5969.0268.5418.9238.8597.9967.57712.5386.4325.202
General & Administrative Expenses 9.74110.3948.2127.0697.8637.0756.35.7526.6675.5545.9235.2235.1864.8284.8163.83.9393.9943.4522.7782.72.3762.0981.5561.0881.1390.885
Selling & Marketing Expenses 0-1.0970-0.00100000000000000000000000
SG&A 9.7419.2978.2127.0687.8637.0756.35.7526.6675.5545.9235.2235.1864.8284.8163.83.9393.9943.4522.7782.72.3762.0981.5561.0881.1390.885
Other Expenses 0-54.533000000000-4.42300000000.00200.006000.0010.0080.068
Operating Expenses 66.89363.8351.01745.83841.56436.25334.15930.46629.03928.3525.57921.33220.68919.80716.38215.85113.96312.5912.47811.31911.62311.23510.0949.13313.6267.5716.087
Operating Income -66.893-64.927-51.017-41.915-33.526-32.709-26.279-26.4440.66-22.499-14.22-18.369-11.713-11.051-9.135-5.28-4.996-12.59-12.478-11.319-11.623-11.235-10.094-9.133-13.626-7.571-6.087
Operating Income Ratio 000-10.684-4.171-9.229-3.335-6.5750.022-3.845-1.252-6.199-1.305-1.262-1.261-0.499-0.5570000000000
Total Other Income Expenses Net 15.07212.15511.4457.966.0864.7832.6392.2420.9550.4430.2070.1570.1310.1040.1140.1450.070.1990.4350.5380.6540.5790.5250.5710.5740.5760.35
Income Before Tax -51.821-52.772-39.572-33.955-27.44-27.926-23.64-24.2011.615-22.056-16.105-18.212-11.582-10.947-9.021-5.135-4.926-12.391-12.043-10.781-10.969-10.656-9.569-8.562-13.052-6.995-5.737
Income Before Tax Ratio 000-8.655-3.414-7.88-3-6.0170.054-3.77-1.418-6.146-1.29-1.25-1.245-0.486-0.5490000000000
Income Tax Expense 00-1.0825.623-1.026-0.998-3.599-2.242-0.955-0.4431.885-20.125-19.9680.04404.769-0.34700-0.8660-0.57300-0.573-0.568-0.282
Net Income -51.821-52.772-39.572-33.955-27.44-27.926-20.041-21.9592.57-21.613-17.99-18.212-11.582-10.947-9.021-5.135-4.926-12.391-12.043-10.781-10.969-10.656-9.569-8.562-13.052-6.995-5.737
Net Income Ratio 000-8.655-3.414-7.88-2.543-5.460.087-3.694-1.584-6.146-1.29-1.25-1.245-0.486-0.5490000000000
EPS -0.6-0.68-0.53-0.52-0.46-0.5-0.41-0.460.064-0.56-0.47-0.47-0.31-0.33-0.28-0.18-0.17-0.59-0.59-0.53-0.54-0.54-0.49-0.6-0.92-0.49-0.4
EPS Diluted -0.6-0.68-0.53-0.52-0.46-0.5-0.41-0.460.063-0.56-0.47-0.47-0.31-0.33-0.28-0.18-0.17-0.59-0.59-0.53-0.54-0.54-0.49-0.6-0.92-0.49-0.4
EBITDA -66.893-64.305-50.401-41.288-32.886-32.09-25.691-25.8851.585-21.639-13.756-17.787-11.262-10.607-8.753-4.919-4.649-12.253-12.142-10.989-11.299-10.937-9.801-8.87-13.403-7.364-5.894
EBITDA Ratio 000-10.424-4.171-9.229-3.335-6.5750.053-3.64-1.027-6.199-1.255-1.211-1.208-0.499-0.5570000000000